Baxter International ended 2024 on a positive note, overcoming challenges posed by Hurricane Helene and delivering better-than-expected Q4 results. The success of the Novum IQ infusion pump ...

The US Food and Drug Administration (FDA) has issued an early alert over a ‘potentially high-risk’ issue with certain Baxter Sigma Spectrum and Spectrum IQ infusion pumps. The agency’s ...

Baxter Healthcare has issued a recall for some Spectrum infusion pumps due to a potential defect involving missing motor mounting screws, which could lead to interruptions, delays or incorrect ...

The survey consisted of items eliciting nurses' concerns regarding the Baxter pumps, suggestions on addressing those concerns, and their overall opinions of the pumps and the quality of care ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. 31, 2024, and provided its ...